{"id":"W2071662566","doi":"10.1002/hep.21209","title":"Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application†","year":2006,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"ca_institutions":"KMT Hepatech (Canada); University of Alberta","funders":"","keywords":"Titer; Hepatitis C virus; Virology; Biology; Interferon; Ribavirin; Immunology; NS5B; Protease inhibitor (pharmacology); NS3; Hepacivirus; Virus; Medicine; Viral load; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001406707,0.0008934878,0.0007731211,0.0007755606,0.0004269797,0.0008271699,0.0004372862,0.0007526051,0.005894901],"category_scores_gemma":[0.0003536346,0.0002852178,0.0005914293,0.0004022207,0.0005837181,0.0007246707,0.0002858982,0.002483269,0.001653577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004536212,"about_ca_system_score_gemma":0.0005139751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003663436,"about_ca_topic_score_gemma":0.0006028627,"domain_scores_codex":[0.9993992,0.0001525144,0.00004819683,0.00009808253,0.000167513,0.000134491],"domain_scores_gemma":[0.9996122,0.00004187863,0.00008430494,0.00009483724,0.0000526539,0.0001142051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003544114,0.001730385,0.0008730267,0.0002013939,0.00005989777,0.0001137698,0.00008477954,0.0003514751,0.9780651,0.000457932,0.001344085,0.01317397],"study_design_scores_gemma":[0.0007727237,0.0238937,0.01063129,0.00005155359,0.0001833269,0.001393322,0.0001286859,0.002301794,0.9434154,0.0002994707,0.01689849,0.00003031263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9594338,0.004439571,0.01557846,0.0008322466,0.0003811597,0.001357227,0.004662325,0.00137019,0.01194489],"genre_scores_gemma":[0.9632716,0.003089436,0.01266364,0.0003984151,0.00009485832,0.001498384,0.005710502,0.0001906435,0.0130826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005894901,"threshold_uncertainty_score":0.01972038,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05062744955841402,"score_gpt":0.4203537846238203,"score_spread":0.3697263350654063,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}